EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H27NO3 |
| Net Charge | 0 |
| Average Mass | 293.407 |
| Monoisotopic Mass | 293.19909 |
| SMILES | CCCCOc1ccc(OCCCN2CCOCC2)cc1 |
| InChI | InChI=1S/C17H27NO3/c1-2-3-12-20-16-5-7-17(8-6-16)21-13-4-9-18-10-14-19-15-11-18/h5-8H,2-4,9-15H2,1H3 |
| InChIKey | DQKXQSGTHWVTAD-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Application: | local anaesthetic Any member of a group of drugs that reversibly inhibit the propagation of signals along nerves. Wide variations in potency, stability, toxicity, water-solubility and duration of action determine the route used for administration, e.g. topical, intravenous, epidural or spinal block. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| pramocaine (CHEBI:8357) has role local anaesthetic (CHEBI:36333) |
| pramocaine (CHEBI:8357) is a aromatic ether (CHEBI:35618) |
| pramocaine (CHEBI:8357) is a morpholines (CHEBI:38785) |
| IUPAC Name |
|---|
| 4-[3-(4-butoxyphenoxy)propyl]morpholine |
| Synonyms | Source |
|---|---|
| Pramoxine | KEGG COMPOUND |
| Pramocaine | KEGG COMPOUND |
| pramocainum | ChemIDplus |
| p-butoxyphenyl γ-morpholinopropyl ether | NIST Chemistry WebBook |
| γ-morpholinopropyl 4-n-butoxyphenyl ether | NIST Chemistry WebBook |
| proxazocain | NIST Chemistry WebBook |
| Citations |
|---|